Market Research Blog

“The global revenue of food grade phosphates market is likely to surpass a value worth US$ 29.5 Bn by the end of 2027,” quotes an F&B expert research analyst at FMI.

Ascending popularity of convenient processed foods can hardly forestall the decline of food grade phosphates market

Although the recent market scenario reflects growing sales of mineral-rich, functional, and fortified food products, FMI predicts that the overall growth of food grade phosphates will remain lethargic throughout the assessment tenure. Research points at immense diversity in convenience food products such as ready-to-eat (RTE) foods and ready-to-drink (RTD) beverages that consume a sizeable volume of food grade phosphates a major ingredient. Moreover, there exists a wide spectrum of food products display across retail formats, pushing the demand for food grade phosphates further.

The food processing industry has been generating consistent demand for food grade phosphates over the years – as a conventional agent for thickening, stabilization, and texture development. FMI estimates passive growth for the global food grade phosphates market, which is likely to be supported by sustained consumption of food grade phosphates by food processors. However, wide availability and sustained tendency of both manufacturers and consumers to prefer natural ingredients will remain the major roadblock to market growth over the next decade.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-894

Retail shelves adopting packaged foods with healthy phosphate ingredients may slightly uplift market scenario

Manufacturers are taking efforts in R&D of food grade phosphates with specific health benefits to appeal to an expanding consumer base seeking health and wellness through food. Moreover, retail players are expected to extend their offerings to include healthy processed foods that contain phosphates with health benefits. Some of the global retail leaders including Walmart Stores, Inc., Tesco PLC, Kroger Company, and Carrefour have already geared up in the game of enhancing their food products display – selling packaged foods that contain a plethora of ingredients such as additives. This will possibly fuel the demand for food grade phosphates in the near future.

Asia Pacific to remain high-potential regional market with relatively

Food grade phosphate manufacturers are concentrating on strategies to expand within developing economies in the Asia Pacific rim to cater to increasing demand for phosphates from agriculture, food, and feed industries. The regional analysis of global food grade phosphates market concludes that Asia Pacific (excluding Japan) will continue to represent the most attractive growth opportunities to market stakeholders. However, although APEJ is anticipated to monopolize the food grade phosphates market with more than 60% value share through 2027, the overall regional market performance will continue to remain declining. According to FMI, emerging markets in APEJ hold immense growth potential but are strongly facing the challenges to growth due to the availability of a myriad alternate ingredients over food grade phosphates.

Key participants in the global food grade phosphates market landscape are foreseen to capitalize on existing opportunities for production capacity expansion in developing regional markets, as it may help them slash overall production costs for additional competitive advantage in terms of pricing and delivery. On other side, food grade phosphates are presumed to witness a slight uptake in North America’s market in the near future. Europe will however represent a passive market for food grade phosphates, as over three-fourth of European population already prefers foods that are devoid of any artificial additives or ingredients.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/894

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Segmental forecast of the global baobab powder market

The global baobab powder is segmented on the basis of product type (organic baobab powder, conventional baobab powder), end use (industrial, retail), sales channel (direct sales, indirect sales) and region.

Forecast by Product Type: Organic baobab powder segment is expected to register the highest CAGR during the forecast period. The organic baobab powder segment is estimated to be valued at US$ 8,544.2 Mn by 2027 end and is expected to expand at a CAGR of 6.5% over the forecast period.

Forecast by End Use: The retail segment is estimated to account for the highest value share of 65.2% in 2017 and is projected to reach a market valuation of US$ 6,545.1 Mn by 2027 end, registering a CAGR of 6.3% over the forecast period.

Forecast by Sales Channel: The indirect segment is estimated to account for the highest value share of 75.4% in 2017. This segment is estimated to be valued at US$ 7,602.1 Mn by 2027 end and is expected to expand at a CAGR of 6.3% over the forecast period.

Forecast by Region: North America followed by Western Europe will be the leading markets in the global baobab powder market with an anticipated value share of about 30% and 25% respectively by the end of 2027. North America will witness the highest regional CAGR of 6.8% during the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3333

Global Baobab Powder Market Forecast 2017-2027

Future Market Insights predicts the global baobab market to be valued at about US$ 5,483 Mn by the end of 2017 and will continue to grow at a CAGR of 6.2% during the period of study to reach a market valuation of about US$ 10,004 Mn by the end of the forecast period.

Competitive Landscape

The report profiles some of the top companies operating in the global baobab powder market including EcoProducts, Baobab Fruit Company Senegal, B’Ayoba (Pvt) Ltd, Organic Africa, Aduna Limited, Etude House, Woodland Foods, Powbab Inc, ATACORA, Halka B. Organics, Indigo Herbs LTD and Organic Burst UK Ltd. Companies are focussing on addressing customer centric product demand by expanding their product portfolio and introducing a variety of products in the global market. Suppliers are entering into long-term contracts with baobab products manufacturers to avoid increase in product prices, and baobab manufacturers are also benefitting from these long-term contracts with suppliers as it helps them sustain their operations.

Segmental forecast of the global aquafeed market

The global aquafeed market is segmented on the basis of species (Crustaceans, Fishes, Others); form (Extruded, Powder, Liquid, Pellets); function (Health, Digestibility, Palatability, Special Nutrition); ingredients (Marine, Land Animal, Veg/Grain, Carotenoid, Nutrients, Others); and sales channel (Direct Sales, Indirect Sales, Hyper/Supermarket, Wholesalers, Speciality Stores, Online, Other Retail Formats).

• The Extruded form type will likely dominate the global aquafeed market in terms of market share – from an estimated 45% value share in 2017 to slightly over 50% by the end of 2027, the segment will record an impressive increase of about 492 basis points in market share. Pellets is likely to hold the second position by form in the global market.
• Fishes segment by species will remain dominant through 2027 with about 50% market share estimated to be held in 2017 and remaining consistent throughout the forecast period. This segment will also record the highest CAGR.
• Vegetable/Grains ingredients segment is expected to show tremendous growth over the forecast period. This segment is poised to witness a growth rate of 6.6% during the forecast period.
• By function, the Digestibility segment will hold high market value share throughout the forecast period – over 30% share of the global market by the end of the forecast period, with an increase of about 138 basis points over the 2017 value share. This segment will register a CAGR of 6.4% in terms of value followed by the Health segment at 6.3% CAGR.
• Direct Sales will remain the favourite segment by sales channel and will hold over 60% of the market share throughout the forecast period. This segment is anticipated to be valued at over US$ 30 Bn in 2017.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4540

Global Aquafeed Market Forecast 2017 – 2027

The new report by Future Market Insights titled “Aquafeed Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” forecasts the global aquafeed market to be valued at about US$ 50 Bn by the end of 2017 and will continue to grow at a CAGR of 5.9% during the period of study to reach a market valuation of about US$ 86 Bn by the end of the forecast period.

Competitive landscape

The report profiles some of the top companies operating in the global aquafeed market including Cargill Inc., Koninklijke DSM N.V., BENEO GmbH, Sonac B.V, ADM, Novus International, Biomin Holding GmbH, Nutriad NV, Alltech Inc., Norel SA, Cermaq, Skretting, Aller Aqua A/S, Clextral, Dibaq, Biomar, Zeigler Bros., Inc., Ridley Corporation Limited, Nutreco N.V., and INVE Aquaculture Inc. Major aquafeed manufacturers in developed and emerging economies are focussing on functional features enhancement in their aquafeed using ingredients that focus on digestibility factors.

Increasing prevalence of sleep disorders, especially in the U.S. and other European countries, creates lucrative growth opportunities for the sleep testing respiratory devices market. According to the National Healthy Sleep Awareness Project, around 25 million adults in the U.S. were suffering from sleep apnea.  Continuous focus on the market introduction of technologically advanced respiratory devices such as nebulizers, pulse oximeters and spirometers is expected to drive the respiratory devices market growth during the forecast period.

“Continuous technological assessment for the development of respiratory devices with greater accuracy and growing adoption of portable and wearable respiratory devices are projected to propel the growth of the global respiratory devices market,” said an FMI Analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Growing preference for smart or wearable respiratory devices over general respiratory devices in developed countries also creates a significant opportunity for global market players operating in the respiratory devices market. Adoption of portable devices for neonatal and adults suffering respiratory diseases is growing respiratory devices demand. For instance, Patients suffering from chronic respiratory diseases require continuous oxygen supply. A portable oxygen concentrator has several other benefits such as lightweight, small shape and easy to carry, which makes it the best choice of device.

Hospitals are likely to remain chief end users of respiratory devices. They have been relentlessly offering patient care amid COVID-19 outbreak. Even as numbers of COVID-19 patients soared, healthcare centers around the world pushed through challenges to offer required care. Hospitals therefore accounted for a little above 40% of respiratory devices sold in 2020. By 2031, the number of respiratory devices sold in hospitals is expected to rise further.

Key Takeaways of Respiratory Devices Market Study

• Respiratory devices market will exhibit impressive growth through 2031. The market is forecast to exhibit 9.3% CAGR in 2021
• U.S. will remain the most lucrative market, accounting for almost 87% of respiratory devices sold in North America
• UK will exhibit impressive Y-o-Y growth at 10.5% in 2021
• Germany and France will continue exhibiting high demand for respiratory devices
• China and Korea will remain bright spots in East Asia market, however, Japan will remain dominant through the forecast period

Partnerships to Develop New Products – Imperative Strategy for Market PlayersLeading manufacturers of the respiratory inhaler are focusing on strategic partnerships with software and digital companies to serve the selected population. Besides, such collaborations also help manufacturers improve their distribution channels as well as to launch their products. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.

Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

What else is in the report?Future market insights offer a unique perspective and actionable insights on Respiratory Devices market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product type (Respiratory Consumables, Nebulizers, Oxygen Concentrators, Positive Airway Pressure (PAP) Devices, Polysomnography Devices, Pulse Oximeters, Mechanical Ventilators, Spirometers), by end-users (hospitals, ambulatory surgical centres, clinics, long term care centres and others) in seven key regions.

Respiratory Devices Market – Key SegmentsProduct

• Respiratory Consumables
  • Respiratory Mask
  • Nasal Cannulas
  • Oxygen Tubing Sets
  • Breathing Filters
• Nebulizers
  • Compressed Jet Nebulizers
  • Ultrasonic Nebulizers
• Oxygen Concentrators
  • Home Oxygen Concentrators
  • Portable Oxygen
  • Concentrators`
• Positive Airway Pressure (PAP) Devices
• Polysomnography Devices
  • Ambulatory PSG Devices
  • Clinical PSG Devices
• Pulse Oximeters
• Mechanical Ventilators
• Spirometers

End Users

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Long Term Care Centers
• Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-794

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• The Middle East and Africa (MEA)
• Oceania

The National Ambulatory Medical Care Survey indicated that Americans made more than 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis present to primary and urgent care providers, which accounts for 1% of all primary care office visits. Adenoviruses account for 65 to 90% of cases of viral conjunctivitis.

The soaring cases of eye infections have been driving ophthalmic eye drops sales. While the report presents positive outlook for growth, ongoing restrictions amid COVID-19 outbreak might hamper sales.

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development and shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from increasing use of contact lens are expected to boost the growth of the ophthalmic eye drops market.” says the FMI Analyst

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13140

Key Takeaways from Ophthalmic Eye Drops Market Study

• Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
• The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
• Rising cases of eye infection will drive sales in the U.K., enabling it register 3.9% y-o-y growth in 2021
• Rising willingness to spend on advanced eye care will drive sales in Germany and France
• Expansion of the healthcare sector will emerge as chief growth driver in China and Japan. Both countries will exhibit high demand for dilation drops

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact-lens wearers were reported at least one contact lens – related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance their presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

• In November 2020, Gerresheimer Regensburg announced that it is expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
• In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third largest generics market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13140

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

Ophthalmic Eye Drops Market by CategoryDrug Class

• Anesthetic Drops
• Dilation Drops
• Glaucoma Drops
• Steroid Drops
• Antibiotic Drops
• Others (Antihistamine, Lubricants Tear Drops)

Indication

• Dry Eye
• Eye Allergy
• Glaucoma
• Eye Infection
• Retinal Disorders
  • Macular Degeneration
  • Diabetic Retinopathy
  • Others
• Uveitis
• Others

Drug Formulation

• With Preservative
• Preservative Free

Container Type

• Single Dose Container
• Multiple-Dose Container

Distribution Channel

• Institutional Sales
  • Hospitals
  • Community Clinics
  • Ophthalmic Clinics
  •  Public Health Agencies
  • Veterinary Hospitals & Clinics
• Retail Sales
  • Retail Pharmacies
  •  Drug Stores

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13140

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/